The long-term use of ipamorelin for increasing GH secretion has yet to be studied and findings are, at best, preliminary [11]
Semaglutide significantly increases the risk of diarrhea (relative risk 2.66 in the meta-analysis), and nausea affects up to 40% of users, particularly during the early weeks of treatment
The key is implementing proper nutrition, hydration, and activity strategies during the adjustment period
Your healthcare provider or pharmacist can show you how to give yourself the injection
Ying Tian, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers